Health and Happiness (H&H) International Holdings (1112) AI Stock Analysis

• Market Cap: $8.51B
• Dividend Yield: 1.85%
• Average Volume (3M): 2.16M
• Price to Earnings (P/E): ―
• Beta (1Y): 0.83
• Revenue Growth: -2.15%
• EPS Growth: -202.71%
• Country: HK
• Employees: 2,800
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Packaged Foods
• EPS (TTM): 0.62
• Shares Outstanding: 645,561,340
• 10 Day Avg. Volume: 2,229,306
• 30 Day Avg. Volume: 2,160,948
• PEG Ratio: 0.91
• Price to Book (P/B): 0.92
• Price to Sales (P/S): 0.41
• P/FCF Ratio: 4.27
• Enterprise Value/Market Cap: 1.82
• Enterprise Value/Revenue: 1.16
• Enterprise Value/Gross Profit: 1.90
• Enterprise Value/Ebitda: 11.19
• 1Y Price Target: $16.48
• Price Target Upside: 27.74% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 7

• Rating: 58 Neutral
• Price Target: HK$13.50 ▲(4.65% Upside)

The overall stock score is primarily influenced by the company's strong cash flow generation and gross margins, which are offset by declining revenue, net losses, and high leverage. Technical analysis indicates mixed signals with potential bearish momentum, while valuation concerns arise from a negative P/E ratio. The absence of earnings call data and corporate events limits additional insights.

Health and Happiness (H&H) International Holdings Business Overview & Revenue Model

Company Description

Health and Happiness (H&H) International Holdings Limited, an investment holding company, manufactures and sells family nutrition and baby care products worldwide. The company's Infant Formulas segment produces infant formulas for children under seven years old and milk formulas for expectant and nursing mothers. Its Probiotic Supplements segment offers probiotic supplements in the form of sachets, capsules, and tablets for infants, children, and expectant mothers. The company's Adult Nutrition and Care Products segment produces vitamins, health supplements, and skincare and sports nutrition products for adults. Its Other Pediatric Products segment produces dried baby food and nutrition supplements, and baby care products. The company's Pet Nutrition and Care products segment produces food, health supplements, and bone broth products for pets. It is also involved in the research, development, and processing of meat, fruit, and vegetable powder and candy; research, development, manufacture, and sale of special nutritional foods; marketing and distribution of organic baby foods; and wholesale, retail, import, and export of nutritional food and personal care products for infants. In addition, the company engages in the trading and sale of vitamins, health supplements, probiotic skin care, and sports nutrition products for adults; and provision of online sales, software, and information technology services, as well as packaging services. It provides its products under the Biostime, Swisse, Aurelia, Zesty Paws, Solid Gold, Dodie, Good Gout, Aurelia London, and CBII brands. The company was formerly known as Biostime International Holdings Limited and changed its name to Health and Happiness (H&H) International Holdings Limited in June 2017. The company was founded in 1999 and is headquartered in Quarry Bay, Hong Kong. Health and Happiness (H&H) International Holdings Limited is a subsidiary of Biostime Pharmaceuticals (China) Limited.

How the Company Makes Money

H&H International Holdings generates revenue through the sale of its diverse range of health and wellness products across multiple segments. The company's key revenue streams include infant nutrition products, such as milk formulas and supplements under the Biostime brand, adult nutrition supplements under the Swisse brand, and pet nutrition products through the Solid Gold brand. H&H leverages its strong brand recognition, extensive distribution networks, and strategic partnerships to expand its market reach globally. The company also invests in research and development to innovate and cater to changing consumer demands, contributing to its earnings growth. Additionally, H&H benefits from strategic acquisitions that enhance its product offerings and geographic presence, further driving its revenue.

Health and Happiness (H&H) International Holdings Financial Statement Overview

Summary

The company shows strong gross margins and cash flow generation, but faces challenges with declining revenue and a net loss impacting profitability and ROE. High leverage is a risk, but stable cash flows provide a buffer.

Income Statement

The company exhibits a mixed income statement with some strengths and weaknesses. The Gross Profit Margin for 2024 is approximately 60.64%, which indicates strong profitability at the gross level. However, the Net Profit Margin is negative at -0.41%, which is concerning, primarily due to a net loss in 2024. Revenue has decreased by 6.28% from 2023 to 2024, indicating challenges in maintaining growth. EBIT Margin stands at 12.04%, and EBITDA Margin at 10.48%, both indicating operational profitability but showing a decline from previous years.

Balance Sheet

The balance sheet reveals some stability but also areas of concern. The Debt-to-Equity Ratio is 1.61 for 2024, indicating a relatively high level of leverage which could pose risks in a volatile market. Return on Equity (ROE) is negative due to the net loss, which is a concern. However, the Equity Ratio is 30.85%, suggesting a reasonable proportion of equity financing, which provides a cushion against liabilities.

Cash Flow

Cash flow analysis shows a robust operating cash flow of HK$1,346 million in 2024, which indicates good cash generation capability. Free Cash Flow increased by 24.19% from 2023 to 2024, indicating strong cash management. The Operating Cash Flow to Net Income Ratio is negative due to net loss, but Free Cash Flow remains strong, demonstrating the company's ability to generate cash despite profitability challenges.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	13.38B	13.05B	13.93B	12.78B	11.55B	11.19B
Gross Profit	8.19B	7.92B	8.47B	7.70B	7.25B	7.19B
EBITDA	1.39B	1.37B	2.04B	1.87B	1.42B	2.13B
Net Income	-288.51M	-53.72M	581.85M	611.78M	508.48M	1.14B
Balance Sheet
Total Assets	19.40B	18.84B	20.04B	20.96B	20.28B	17.22B
Cash, Cash Equivalents and Short-Term Investments	1.81B	1.60B	1.45B	2.30B	2.40B	1.83B
Total Debt	9.31B	9.36B	9.22B	9.67B	9.48B	6.17B
Total Liabilities	13.39B	13.03B	13.75B	14.82B	14.40B	11.02B
Stockholders Equity	6.01B	5.81B	6.30B	6.14B	5.89B	6.20B
Cash Flow
Free Cash Flow	1.19B	1.25B	1.01B	1.37B	1.78B	1.43B
Operating Cash Flow	1.29B	1.35B	1.10B	1.47B	1.89B	1.53B
Investing Cash Flow	-38.88M	895.00K	-52.07M	-104.88M	-4.01B	-1.24B
Financing Cash Flow	-1.69B	-1.07B	-1.99B	-1.49B	2.77B	-687.68M

Health and Happiness (H&H) International Holdings Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 12.90
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1112, the sentiment is Negative. The current price of 12.9 is below the 20-day moving average (MA) of 13.08, below the 50-day MA of 13.51, and above the 200-day MA of 10.94, indicating a neutral trend. The MACD of -0.12 indicates Positive momentum. The RSI at 44.21 is Neutral, neither overbought nor oversold. The STOCH value of 38.80 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1112.

Health and Happiness (H&H) International Holdings Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
1579	65 Neutral	HK$11.81B	14.76	16.58%	5.99%	1.10%	-7.88%
1717	64 Neutral	HK$4.13B	14.13	4.53%	2.69%	0.52%	99.51%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
1112	58 Neutral	$8.51B	―	-4.66%	1.85%	-2.15%	-202.71%
1475	58 Neutral	HK$7.19B	38.15	5.18%	1.56%	7.44%	-42.52%
9676	58 Neutral	HK$14.61B	39.50	5.56%	2.34%	―	―
0345	57 Neutral	HK$8.44B	36.71	7.71%	1.82%	0.91%	101.66%

Health and Happiness (H&H) International Holdings Corporate Events

Health and Happiness (H&H) Reports Mixed 2025 Interim Results

Health and Happiness (H&H) International Holdings Limited is a Cayman Islands-incorporated company focusing on the manufacture and sale of premium nutrition and care products for adults, babies, and pets. The company operates in the consumer goods sector, distinguished by its emphasis on high-quality, health-focused products.

H&H International Declares Interim Dividend for 2025

Health and Happiness (H&H) International Holdings Limited announced an interim cash dividend of HKD 0.19 per share for the six months ending June 30, 2025. This announcement reflects the company’s ongoing commitment to delivering shareholder value and may positively impact investor sentiment. The dividend will be paid on October 17, 2025, with a record date of September 15, 2025, indicating a stable financial performance and confidence in future growth.

The most recent analyst rating on (HK:1112) stock is a Hold with a HK$12.50 price target. To see the full list of analyst forecasts on Health and Happiness (H&H) International Holdings stock, see the HK:1112 Stock Forecast page.

H&H International Holdings Reports Mixed Interim Results for 2025

Health and Happiness (H&H) International Holdings Limited reported its unaudited interim results for the first half of 2025, showing a 4.9% increase in revenue to RMB 7,019.2 million compared to the same period in 2024. Despite the revenue growth, the company experienced a significant decline in net profit by 76.8% to RMB 71.0 million, attributed to increased finance costs and other non-cash losses. The adjusted net profit, however, saw a slight increase of 4.6% to RMB 363.0 million, indicating some resilience in its core operations. The results suggest challenges in maintaining profitability amidst rising costs, impacting its market positioning and stakeholder confidence.

The most recent analyst rating on (HK:1112) stock is a Hold with a HK$12.50 price target. To see the full list of analyst forecasts on Health and Happiness (H&H) International Holdings stock, see the HK:1112 Stock Forecast page.

H&H International Holdings Updates Board of Directors and Committee Roles

Health and Happiness (H&H) International Holdings Limited has announced the updated list of its board of directors and their respective roles, effective from August 26, 2025. This update includes a mix of executive, non-executive, and independent non-executive directors, reflecting the company’s commitment to a diverse and experienced leadership team. The announcement also details the composition of four key board committees, indicating a structured approach to governance and strategic oversight.

The most recent analyst rating on (HK:1112) stock is a Hold with a HK$12.50 price target. To see the full list of analyst forecasts on Health and Happiness (H&H) International Holdings stock, see the HK:1112 Stock Forecast page.